Cancer Diagnostics Market Size, Share & Growth Analysis Report By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Others), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin, Blood Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer and Others) - Global Industry Analysis, Trends, Segment Forecasts, Regional Outlook 2021 - 2030

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Cancer Diagnostics Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Cancer Diagnostics Market

5.1. Covid-19: Cancer Diagnostics Industry Impact
5.2. Cancer Diagnostics Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Cancer Diagnostics Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Cancer Diagnostics Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Cancer Diagnostics Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Driver 1
6.1.1.2. Driver 2
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2

Chapter 7. Global Cancer Diagnostics Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Cancer Diagnostics Market Revenue by Market Players (2015-2020)
7.1.1.2. Cancer Diagnostics Market Revenue Market Share by Market Players (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Cancer Diagnostics Market, By Product Type

8.1. Cancer Diagnostics Market, by Product Type, 2016-2027
8.1.1. Laboratory Tests
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Genetic Tests
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Imaging
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Endoscopy
8.1.5. Biopsy
8.1.6. Others (barium enema)

Chapter 9. Global Cancer Diagnostics Market, By Application

9.1. Cancer Diagnostics Market, by Application, 2016-2027
9.1.1. Breast Cancer
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Colorectal Cancer
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Cervical Cancer
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Lung Cancer
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Prostate Cancer
9.1.6. Skin Cancer
9.1.7. Blood Cancer
9.1.8. Kidney Cancer
9.1.9. Liver Cancer
9.1.10. Pancreatic Cancer
9.1.11. Ovarian Cancer
9.1.12. Others

Chapter 10. Global Cancer Diagnostics Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue Forecast by Product Type(2016-2027)
10.1.2. Market Revenue Forecast by Application (2016-2027)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2016-2027)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2016-2027)
10.2. Europe
10.2.1. Market Revenue Forecast by Product Type(2016-2027)
10.2.2. Market Revenue Forecast by Application (2016-2027)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2016-2027)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2016-2027)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2016-2027)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2016-2027)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product Type(2016-2027)
10.3.2. Market Revenue Forecast by Application (2016-2027)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2016-2027)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2016-2027)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2016-2027)
10.4. LATAM
10.4.1. Market Revenue Forecast by Product Type(2016-2027)
10.4.2. Market Revenue Forecast by Application (2016-2027)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2016-2027)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2016-2027)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product Type(2016-2027)
10.5.2. Market Revenue Forecast by Application (2016-2027)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2016-2027)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2016-2027)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2016-2027)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2016-2027)

Chapter 11. Company Profiles

11.1. Agilent Technologies, Inc.
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2015-2020)
11.1.4. Recent Developments and Strategies
11.2. Thermo Fisher Scientific, Inc.
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2015-2020)
11.2.4. Recent Developments and Strategies
11.3. Illumina, Inc.
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2015-2020)
11.3.4. Recent Developments and Strategies
11.4. Becton, Dickinson and Company
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2015-2020)
11.4.4. Recent Developments and Strategies
11.5. GE Healthcare
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2015-2020)
11.5.4. Recent Developments and Strategies
11.6. QIAGEN N.V.
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2015-2020)
11.6.4. Recent Developments and Strategies
11.7. Abbott Laboratories, Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2015-2020)
11.7.4. Recent Developments and Strategies
11.8. Roche Diagnostics
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2015-2020)
11.8.4. Recent Developments and Strategies
11.9. Siemens Healthcare
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2015-2020)
11.9.4. Recent Developments and Strategies
11.10. Philips Healthcare
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin (2015-2020)
11.10.4. Recent Developments and Strategies

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence client

Get a Sample